A Potential Source of Anti-Cancer Drugs: Marine Raw Materials

Abstract

Marine populations serve as a repository for novel bioactive metabolites with a wide range of chemical configurations. The influence of marine species is highlighted in this review, with a focus on marine plants, algae, bacteria, actinomycetes, fungi, sponges, and soft corals. Disease ailment patterns are shifting, and new diseases are arising as a result of changing settings. The massive increase in the world’s population has put a strain on the available drug resources. As a result, drug companies are constantly on the search for fresh resources to help them develop effective and safe drugs to meet the growing demands of the global population. The marine environment contains an abundance of various materials for developing novel medications to treat important diseases such as cancer. Cancer is still one of the deadliest diseases on the planet. New medications with novel modes of action are desperately needed, thus much research has been done on new anticancer treatments derived from natural sources, including plants, microorganisms, and marine organisms. The anti-cancer benefits of marine natural products in in vitro and in vivo research were initially discussed, as well as their activity in tumor prevention and associated compoundinduced apoptosis and cytotoxicities.